Global Prevalence of Myopia and High Myopia and Temporal Trends from 2000 through 2050.
Holden BA, Fricke TR, Wilson DA, Jong M, Naidoo KS, Sankaridurg P, Wong TY, Naduvilath TJ, Resnikoff S.
Ophthalmology. 2016 May;123(5):1036-42. doi: 10.1016/j.ophtha.2016.01.006. Epub 2016 Feb 11.
Myopia.
Morgan IG, Ohno-Matsui K, Saw SM.
Lancet. 2012 May 5;379(9827):1739-48. doi: 10.1016/S0140-6736(12)60272-4.
[Myopia in children].
Bremond-Gignac D.
Med Sci (Paris). 2020 Aug-Sep;36(8-9):763-768. doi: 10.1051/medsci/2020131. Epub 2020 Aug 21.
IMI Pathologic Myopia.
Ohno-Matsui K, Wu PC, Yamashiro K, Vutipongsatorn K, Fang Y, Cheung CMG, Lai TYY, Ikuno Y, Cohen SY, Gaudric A, Jonas JB.
Invest Ophthalmol Vis Sci. 2021 Apr 28;62(5):5. doi: 10.1167/iovs.62.5.5.
The epidemics of myopia: Aetiology and prevention.
Morgan IG, French AN, Ashby RS, Guo X, Ding X, He M, Rose KA.
Prog Retin Eye Res. 2018 Jan;62:134-149. doi: 10.1016/j.preteyeres.2017.09.004. Epub 2017 Sep 23.
IMI - Defining and Classifying Myopia: A Proposed Set of Standards for Clinical and Epidemiologic Studies.
Flitcroft DI, He M, Jonas JB, Jong M, Naidoo K, Ohno-Matsui K, Rahi J, Resnikoff S, Vitale S, Yannuzzi L.
Invest Ophthalmol Vis Sci. 2019 Feb 28;60(3):M20-M30. doi: 10.1167/iovs.18-25957.
Myopia and orthokeratology for myopia control.
Cho P, Tan Q.
Clin Exp Optom. 2019 Jul;102(4):364-377. doi: 10.1111/cxo.12839. Epub 2018 Oct 31.
High myopia: Reviews of myopia control strategies and myopia complications.
Shah R, Vlasak N, Evans BJW.
Ophthalmic Physiol Opt. 2024 Sep;44(6):1248-1260. doi: 10.1111/opo.13366. Epub 2024 Jul 31.
IMI Impact of Myopia.
Sankaridurg P, Tahhan N, Kandel H, Naduvilath T, Zou H, Frick KD, Marmamula S, Friedman DS, Lamoureux E, Keeffe J, Walline JJ, Fricke TR, Kovai V, Resnikoff S.
Invest Ophthalmol Vis Sci. 2021 Apr 28;62(5):2. doi: 10.1167/iovs.62.5.2.
Review on the Myopia Pandemic: Epidemiology, Risk Factors, and Prevention.
Landreneau JR, Hesemann NP, Cardonell MA.
Mo Med. 2021 Mar-Apr;118(2):156-163.
